SCHEMBL2908978

SCHEMBL2908978

O=C(O)C(=C(c1ccccc1)c1ccccc1)c1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 5/20 0.50
CES2 O00748 4/20 0.50
TSHR P16473 2/20 0.50
ALDH1A1 P00352 2/20 0.50
DAO P14920 1/20 0.50
NAPRT Q6XQN6 1/20 0.50
TDP1 Q9NUW8 4/20 0.46
CA2 P00918 3/20 0.46
CA12 O43570 3/20 0.46
CA1 P00915 3/20 0.46
CA9 Q16790 3/20 0.46
CYP3A4 P08684 2/20 0.46
MAPT P10636 2/20 0.46
CA4 P22748 2/20 0.46
HSD17B10 Q99714 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
POLB P06746 1/20 0.46
PARP1 P09874 1/20 0.46
CYP2C19 P33261 1/20 0.46
RECQL P46063 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20686416 0.87 CES2 (0.61) CES1CES2ALDH1A1CYP3A4MAPT
SCHEMBL114583 0.86 CES1 (0.58) CES1CES2TSHRALDH1A1DAO
SCHEMBL183462 0.86 CES1 (0.58) CES1CES2TSHRALDH1A1DAO
SCHEMBL523842 0.86 CES1 (0.58) CES1CES2TSHRALDH1A1DAO
SCHEMBL16760711 0.83 CES1 (0.45) CES1CES2TSHRALDH1A1DAO
SCHEMBL29290730 0.81 CES1 (0.52) CES1CES2TSHRALDH1A1DAO
SCHEMBL28604531 0.80 CES1 (0.46) CES1CES2TSHRALDH1A1DAO
SCHEMBL4443220 0.80 CES1 (0.46) CES1CES2TSHRALDH1A1DAO
SCHEMBL5425618 0.80 TDP1 (0.54) CES1CES2TSHRALDH1A1DAO
SCHEMBL1647969 0.79 TDP1 (0.52) CES1CES2TSHRALDH1A1DAO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016088138-A1 DIPHENYLOXIRANES, PROCESS FOR PREPARATION THEREOF, AND ITS USE IN AN ENANTIOSELECTIVE SYNTHESIS OF (+)-SERTRALINE COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2016-06-09 WO claimed
CN-106604935-B Method for producing terminal-modified conjugated diene polymer, rubber composition, and tire 株式会社普利司通 2019-02-22 CN disclosed
CN-109153737-A The manufacturing method of terminal-modified conjugated diolefin polymer, rubber composition, rubber product and terminal-modified conjugated diolefin polymer 株式会社普利司通 2019-01-04 CN disclosed
CN-106604935-A Method for producing terminal-modified conjugated diene polymer, rubber composition, and tire 株式会社普利司通 2017-04-26 CN disclosed
WO-2016088138-A1 DIPHENYLOXIRANES, PROCESS FOR PREPARATION THEREOF, AND ITS USE IN AN ENANTIOSELECTIVE SYNTHESIS OF (+)-SERTRALINE COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2016-06-09 WO disclosed
CN-102164512-A Beverage composition and method of reducing degradation of monatin PEPSICO INC 2011-08-24 CN disclosed
EP-1699873-B1 COSMETIC APPLICATION OF ROD-COIL POLYMERS OREAL (FR) 2010-08-11 EP disclosed
US-20070098664-A1 Cosmetic application of rod-coil copolymers L'OREAL (FR) 2007-05-03 US disclosed
EP-1699873-A1 COSMETIC APPLICATION OF ROD-COIL POLYMERS L'OREAL (FR) 2006-09-13 EP disclosed
WO-2005059032-A1 COSMETIC APPLICATION OF ROD-COIL POLYMERS L'OREAL (FR) 2005-06-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070098664-A1 Cosmetic application of rod-coil copolymers COIL, CRYAB, CRYZ CES1 3405/4885CES2 2604/4885TSHR 311/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.